Stock Selection: GPT-6's picks for 2026-10-20
GPT-6 picked SOXL, MMM, ISRG, NOC, RTX for a 1-day horizon. Portfolio return vs SPY: -1.18%. Picks that beat SPY: 0%.
| Experiment | Stock Selection |
|---|---|
| Model | GPT-6 |
| Prompt version | stock-selection-v8 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-20 |
| Measured to | 2026-10-21 |
| Benchmark | SPY |
| Status | Settled |
| Portfolio return vs SPY | -1.18% |
| Picks that beat SPY | 0% |
| Benchmark return | -0.15% |
The picks
| Rank | Symbol | Return | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|
| 1 | SOXL | -0.83% | 58% | -0.68% | No |
| 2 | MMM | -1.00% | 61% | -0.85% | No |
| 3 | ISRG | -2.40% | 54% | -2.24% | No |
| 4 | NOC | -1.03% | 56% | -0.88% | No |
| 5 | RTX | -1.38% | 57% | -1.23% | No |
The model's market view
Modestly bullish but highly selective, with elevated volatility. U.S. equities recovered from early weakness on October 20 as corporate earnings helped offset concerns about elevated oil prices, inflation, interest rates, and AI infrastructure spending. Semiconductor stocks staged a notable intraday reversal after a prolonged selloff, while aerospace, defense, and industrial companies reported generally strong quarterly results. The preferred approach is to combine semiconductor recovery potential with company-specific earnings catalysts and defensive industrial exposure. The five equal-weight selections are SOXL, MMM, ISRG, NOC, and RTX. SOXL provides amplified exposure to a possible semiconductor rebound; MMM benefits from raised earnings guidance and a newly announced Amazon optical-connectivity agreement; ISRG has an earnings announcement expected after the October 20 close; NOC and RTX benefit from strong reported defense demand and improved earnings outlooks. The principal risks are an abrupt reversal in semiconductor sentiment, profit-taking after positive earnings announcements, renewed geopolitical escalation, and disappointing overnight guidance from Intuitive Surgical. The forecast applies strictly to the authoritative window from 2026-10-20T14:57:14.412Z to 2026-10-21T14:57:00.000Z. Price changes that occurred before the window began are historical observations and are not included in the expected remaining opportunity. Reference prices are the latest independently retrieved intraday quotes, with source timestamps ranging from 10:28 AM to 10:54 AM Eastern on October 20. These snapshots precede the authoritative window start and are not guaranteed execution prices. The source pages label their quotes real-time, but synchronized quote freshness cannot be independently guaranteed. The objective is to outperform SPY over one trading session, not necessarily to produce positive absolute returns.
Why each pick
SOXL
THESIS: A tactical semiconductor rebound offers the largest potential one-session upside relative to SPY among these selections. Semiconductor stocks experienced an extended decline before recovering on October 19. Market reporting indicated that the Philadelphia Semiconductor Index had fallen approximately 15.7% during an eight-session losing streak before rebounding. On October 20, the index initially fell as much as 2.4% but reversed during the opening hour, with most components participating in the recovery. This improving breadth supports the possibility of additional short-term buying. SOXL provides approximately three times the daily performance of the NYSE Semiconductor Index before expenses, creating substantial upside potential if the sector continues outperforming the broader market. PRICE ACTION: SOXL opened October 20 at $94.52, reached an observed intraday low of $91.35, and subsequently recovered toward $101.69. The observed rebound is already reflected in the available quote and must not be counted as future performance. The intraday high was $102.62. A renewed move above that level would strengthen the continuation thesis. CATALYSTS: The rebound in semiconductor sentiment, recovery in NVIDIA and AMD, and expectations surrounding upcoming semiconductor earnings could support further sector rotation. These are expectations rather than confirmed future outcomes. RISKS: The rebound followed a substantial selloff driven by concerns about AI capital expenditure, financing costs, inflation, and interest rates. Renewed weakness in AI stocks or disappointing semiconductor guidance could reverse the rally rapidly. SOXL's daily leverage substantially magnifies losses, and its return over an intraday-to-intraday holding period need not equal three times the underlying index's return. A sustained decline below $94.52 would materially weaken the recovery thesis. FORECAST: Moderate probability of strong positive relative performance, with unusually high downside volatility. QUOTE: $101.69, October 20, 2026 at 10:46 AM EDT, source-labelled real-time regular-session price. EVIDENCE: https://www.marketwatch.com/livecoverage/stock-market-today-nasdaq-lower-dow-sp500-up-after-rally-spacex-and-netflix-earnings/card/chip-stocks-pull-a-u-turn-and-are-now-extending-their-bounce-2vr8TGJrl6IaXo5FWPmW ; https://www.direxion.com/product/daily-semiconductor-bull-bear-3x-etfs
MMM
THESIS: 3M combines a positive earnings surprise with an independently significant commercial catalyst involving Amazon and AI data-center infrastructure. On October 20, 3M reported adjusted third-quarter EPS of $2.50, compared with expectations around $2.39, and adjusted sales of approximately $6.6 billion. Adjusted operating margin reached 26.2%, reflecting an improvement in operating performance. Management increased its 2026 adjusted EPS outlook to $9.10–$9.15. More importantly for potential continued investor interest, 3M announced an expanded commercial relationship with Amazon involving optical connectivity and data-center products. Amazon received warrants to purchase up to approximately 3.2 million shares, subject to cumulative purchases and other milestones. The associated commercial agreement includes a potential $6 billion purchasing threshold over seven years; that amount is not guaranteed revenue. PRICE ACTION: Shares advanced sharply following these announcements. The retrieved intraday quote of $169.69 represented a gain of approximately 4.74% over the previous closing price of $162.01. The observed intraday high was $171.45. The positive earnings reaction has therefore already occurred, and this selection depends on additional buying or follow-through after the quoted price rather than repeating the existing gain. CATALYSTS: Higher earnings expectations, improved margins, new AI infrastructure exposure, and potential subsequent analyst revisions. RISKS: A substantial portion of the positive information may already be priced in. Investors may sell into the strength, especially if management's guidance improvement is perceived as predominantly cost-driven rather than demand-driven. Inflation, tariffs, weaker industrial demand, and legacy litigation exposures remain important risks. A sustained decline below the observed opening price of $163.00 would weaken the near-term continuation thesis. FORECAST: Above-benchmark performance driven by earnings revisions and renewed appreciation of 3M's data-center opportunity. QUOTE: $169.69, October 20, 2026 at 10:28 AM EDT, source-labelled real-time regular-session price. This quote is older than the other selected snapshots, limiting confidence in its freshness. EVIDENCE: https://investors.3m.com/news-events/press-releases/detail/1946/3m-reports-third-quarter-2026-results-raises-full-year-eps ; https://www.reuters.com/business/retail-consumer/3m-lifts-annual-profit-forecast-cost-controls-price-hikes-2026-10-20/
ISRG
THESIS: Intuitive Surgical offers a company-specific overnight earnings catalyst with potential upside unrelated to the broad semiconductor recovery. The company is scheduled to hold its third-quarter 2026 earnings conference call on October 20 at 1:30 PM Pacific, following the regular-session close. Results and management guidance were not yet known at the forecast snapshot. Intuitive benefits from recurring instruments and accessories revenue, continued adoption of robotic-assisted surgery, and expansion of the da Vinci surgical platform. These structural advantages could support favorable investor interpretation if quarterly procedure growth, system placements, and margins meet or exceed expectations. PRICE ACTION: The October 19 completed-session close was $433.18, following an advance from the previous session. October 20 opened at $433.50, and the latest retrieved quote was $435.94, up approximately 0.64% from the prior close. The observed intraday range was $432.00–$437.00. The relatively limited pre-announcement advance suggests that a material earnings reaction has not yet occurred, although it does not establish that upside is underpriced. CATALYST: The officially scheduled October 20 earnings conference call and anticipated quarterly financial results. Better-than-expected procedure growth, improved system placements, or favorable forward guidance could trigger positive opening-price adjustment on October 21, within the authoritative evaluation window. RISKS: This is a binary overnight earnings exposure. A weaker-than-expected result could produce a substantial gap lower. The company trades at a significant valuation premium, with the retrieved trailing price-to-earnings multiple near 50. Competition, hospital capital spending limitations, and margin pressures could outweigh strong long-term growth. The positive thesis would weaken considerably if earnings guidance disappoints or shares sustain a decline beneath the recent $419–$420 support area. FORECAST: A moderately positive earnings surprise and favorable subsequent price adjustment, with lower confidence because no actual quarterly results were available. QUOTE: $435.94, October 20, 2026 at 10:54 AM EDT, source-labelled real-time regular-session price. EVIDENCE: https://investor.intuitivesurgical.com/events/event-details/q3-2026-intuitive-earnings-conference-call
NOC
THESIS: Northrop Grumman presents an earnings-driven continuation opportunity supported by increased defense spending, record backlog, and stronger management guidance. On October 20, the company reported third-quarter revenue of approximately $11.1 billion, an increase of 7% year over year, diluted EPS of $7.89, and approximately $16 billion in new awards. The book-to-bill ratio reached approximately 1.5, while backlog increased to approximately $110 billion. Management also raised its 2026 outlook for segment operating income and adjusted earnings. The updated adjusted EPS outlook was approximately $29.35–$29.75, compared with the previous $28.60–$29.10 range. These figures support improved future earnings expectations rather than representing merely speculative enthusiasm. PRICE ACTION: Shares advanced approximately 6.11% to the verified quote of $541.85, compared with the October 19 close of $510.65. The stock opened October 20 at $523.64 and traded as high as $550.89. The strong opening reaction demonstrates investor approval of the results, although the subsequent retreat from the intraday high indicates profit-taking. The initial 6.11% advance has already occurred and is not part of the prospective return. CATALYSTS: Further interpretation of the guidance increase, record backlog, sustained demand for missile defense and advanced weapons, and potential analyst earnings revisions. RISKS: Much of the earnings surprise may already be incorporated into the stock price. A failed recovery toward $550.89 could lead to short-term consolidation. Defense procurement timing, production execution, cost overruns, and supply-chain constraints remain material risks. A sustained move below the observed $523.64 opening level would challenge the immediate continuation thesis. FORECAST: Modest additional upside versus SPY, with the expectation that the fundamentally supported earnings revision outweighs near-term profit-taking. QUOTE: $541.85, October 20, 2026 at 10:50 AM EDT, source-labelled real-time regular-session price. EVIDENCE: https://investor.northropgrumman.com/static-files/db36842f-1e3f-449c-8d19-6221f5aca190
RTX
THESIS: RTX combines strong aerospace aftermarket demand with a substantial defense backlog and a meaningful increase in annual guidance. The company's October 20 third-quarter results showed revenue of approximately $25 billion, up 11% year over year, and adjusted EPS of $2.26, exceeding analyst expectations of approximately $1.78. The company raised full-year adjusted EPS guidance to $7.65–$7.75 from $7.10–$7.25 and raised adjusted revenue guidance to $97.0–$97.5 billion. Its reported backlog reached $340 billion, including $176 billion commercial and $164 billion defense. These results provide concrete evidence of strong demand across multiple business segments. An important qualification is that quarterly adjusted EPS included $0.25 from IEEPA cost recovery, which should not be treated as recurring operational growth. PRICE ACTION: RTX closed October 19 at $192.11 and opened October 20 at $193.28. The stock traded between $188.08 and $197.00 before the retrieved quote of $193.49, representing a modest 0.72% gain over the previous close. The retreat from the intraday high indicates that investors are not uniformly interpreting the earnings report positively. Unlike NOC, much of the apparent improvement in RTX's outlook has not translated into an equally large sustained share-price increase. That leaves room for relative outperformance if buying interest returns, but also suggests caution about underlying market sentiment. CATALYSTS: Raised annual guidance, strong commercial aftermarket activity, record defense awards, and potential favorable earnings-estimate revisions. RISKS: The earnings improvement contains a nonrecurring cost-recovery component. Aerospace supply-chain constraints, military program execution costs, and valuation concerns may limit further gains. The observed rejection near $197 is negative short-term evidence. A sustained decline below the October 20 low of $188.08 would undermine the continuation thesis, while a recovery above $197 would strengthen it. FORECAST: Modest additional positive return relative to SPY, supported by guidance revisions and diversified aerospace and defense demand. QUOTE: $193.49, October 20, 2026 at 10:51 AM EDT, source-labelled real-time regular-session price. EVIDENCE: https://www.rtx.com/news/news-center/2026/10/20/rtx-reports-q3-2026-results ; https://www.reuters.com/business/aerospace-defense/rtx-lifts-2026-forecasts-aerospace-defense-demand-drives-record-backlog-2026-10-20/
Other models on the same run
| Model | Picks | Portfolio return vs SPY | Picks that beat SPY |
|---|---|---|---|
| Claude Sonnet 5.5 | COF, ISRG, NFLX, RSP, XLE | -0.63% | 60% |
| Muse Spark 1.1 | NVDA, TSM, AVGO, MSFT, AAPL | +0.14% | 60% |
| Perplexity | LLY, MMM, NOC, WDC, MU | -0.16% | 20% |
| Gemini 3 Pro | XOM, CVX, MMM, RTX, AMZN | +0.16% | 40% |
| Grok 4.5 | BRZE, EFX, NOC, HAL, XLE | +0.75% | 80% |
| DeepSeek | HAS, MMM, EFX, NOC, LLY | +0.46% | 40% |
Written up on ForecastNest Insights: Stock Selection: GPT-6's picks for 2026-10-20.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.